ARTICLE | Financial News
Addex proposes CHF40M private placement
February 23, 2018 3:24 PM UTC
Neurology company Addex Therapeutics Ltd. (SIX:ADXN) proposed on Feb. 15 to raise up to CHF40 million ($42.7 million) through the sale of 12.8 million shares at CHF3.43 in a private placement. The company said CHF30 million of the offering has been committed by New Enterprise Associates, New Leaf Venture Partners, CAM Capital and clients of Herculis Partners and Semper Finance Group.
Investors will also receive seven-year warrants to purchase shares at CHF3.43. The company will ask shareholders to vote on the offering in March...
BCIQ Company Profiles
BCIQ Target Profiles